Publication of Q1 report January – March 2025
OSLO, NORWAY – May 27 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the interim report for the period January 1 – March 31, 2025. The interim report…
Genetic Analysis AS: Mandatory notification of trade
OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have been allocated GEAN shares in connection with the…
Minutes from the Annual General Meeting 2024 in Genetic Analysis AS
OSLO, NORWAY – 20 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) held its Annual General Meeting yesterday, May 19th, at 15:00 hours (CET) on the Company’s premises in…
Notice of Annual General Meeting
OSLO, NORWAY – 5 May 2025: Notice is hereby served that the annual general meeting in Genetic Analysis AS (the “Company”) will be held on Monday 19 May 2025 at…
Genetic Analysis announces proposed changes to the Board
OSLO, NORWAY – 5 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) today announces that its Election Committee has proposed the appointment of Mr. Morten Jurs as the new…
Genetic Analysis announces placement of a directed share issue of NOK 12.8 million
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis AS publishes Annual Report 2024
OSLO, NORWAY – 2 May 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishesthe Annual Report for the financial year of 2024. The Annual Report is available as an…
Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market
OSLO, NORWAY/SHANGHAI, CHINA – 22. April 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Thalys Medical Technology Group Corporation (“Thalys”) announces the launch of a microbiome test for the…
Genetic Analysis AS publishes year-end report 2024
OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the year-end report for the period 1 January – December 31, 2024. The year-end report…
Genetic Analysis and Ferring Pharmaceuticals Announce A Collaboration To Develop A New Microbiome Rapid Diagnostic Test
Oslo, Norway – 20 December, 2024 – Ferring Pharmaceuticals and microbiome diagnostics specialists Genetic Analysis will bring together two established technologies – Genetic Analysis’ PCR-based microbiome diagnostics platform (GA-map®1) and…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has bought GEAN-shares. Ronny Hermansen, CEO of Genetic Analysis AS, has…
Publication of Q3 Interim Report January – September 2024
OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the third quarter and the first nine months of 2024. The interim…
Publication of Half-year report 2024
OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for H1, and april – June 2024. The Half-year…
Genetic Analysis AS launches the GA-map® Discovery reagent kit – a precision microbiome research assay
OSLO, NORWAY – 15 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces the launch of a microbiome research product for Luminex xMAP® users globally. The…
Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map® technology
OSLO, NORWAY – August 8, 2024: Microbiome DX company Genetic Analysis AS (“GA”) announces the completion and launch of a consumer microbiome testing platform in partnership with Prokarimi AS (“Prokarimi”)….